Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study

NCT01772251 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Insulin-Dependent, 1

Interventions

DRUG: Oshadi Icp

Sponsor

Oshadi Drug Administration